The bull thesis on bio-pharmaceutical company Amarin (NASDAQ:AMRN) for 2020 is pretty simple. The company’s core drug, Vascepa, is in the early innings of a huge multi-year growth trajectory. In 2020, several catalysts will meaningfully accelerate Vascepa’s growth trajectory. As they do, the company’s revenues and profits will continue to soar. Source: Pavel Kapysh / Shutterstock.com Amarin
Month: February 2020
Britain’s Prince Harry speaks at Windsor Castle in Berkshire, Britain May 6, 2019. Steve Parsons | Pool | Reuters Goldman Sachs is in discussions to feature Prince Harry as a guest speaker for its interview series “Talks at GS,” according to a person with knowledge of the situation. The Duke of Sussex will likely want
Year-to-date, Beyond Meat (NASDAQ:BYND) stock is up an eye-popping 54%. Yet that BYND share price is still more than 50% below its all-time high of $239.71 seen on July 26, 2019, leaving many investors wondering if now maybe a good time to buy into the shares. Source: calimedia / Shutterstock.com As the California-headquartered company is scheduled
Follow markets long enough and you’re bound to hear some speculation regarding the efficacy of Chinese data. Meaning that there are plenty of folks out there that think economic numbers out of the world’s second-largest economy may not always be accurate. Source: Provided by Finviz What is not up for debate, however, is that the
In a column about Chinese coffee retailer Luckin (NASDAQ:LK) from on Jan. 23, I urged investors to “wait for the coronavirus to be contained before buying Luckin’s shares.” I added that “people thinking about buying the stock for the first time should at least wait until the (Chinese) New Year holiday is over or until
If you’re a CEO hoping to give your stock a boost over time, you may want to start mentioning “growth” and “expansion” more often on earnings calls. Shares of companies with chief executives who made liberal use of positive words to describe financials during earnings conference calls outperformed those at businesses with more reserved CEOs,
Check out the latest Zacks Personal Finance 101 video for the key differences between single and married withholding.
As the vast majority of marijuana stocks have tumbled over the last 11 months, even most bulls have given up on many of the names, including Hexo (NYSE:HEXO), Tilray (NASDAQ:TLRY), and Aurora Cannabis (NYSE:ACB). But the bulls have still been extremely upbeat on Aphria (NYSE:APHA), but it’s hard to say why people still like Aphria
Friday marked a quiet day for the indices, but a loud day for earnings. That said, let’s look at a few top stock trades as we head into the long holiday weekend. Top Stock Trades for Tuesday No. 1: Roku (ROKU) Man, did the trade in Roku (NASDAQ:ROKU) work out well or what? After better-than-expected
Investors might be tempted to take profits in Teladoc Health (NYSE:TDOC). After all, TDOC stock has gained 900% from its 2016 lows. And it certainly looks expensive. The provider of virtual healthcare services now has a market capitalization over $8 billion. Source: Piotr Swat / Shutterstock.com Yet Teladoc isn’t profitable, and likely won’t be until
CNBC’s Jim Cramer on Wednesday blasted Bed Bath & Beyond‘s decision to announce disappointing same-store sales figures well ahead of its fourth-quarter earnings release. However, Cramer said investors could use the subsequent stock plunge as a buying opportunity. “I would buy it,” he added. Bed Bath & Beyond shares sank about 25% on Wednesday after
If one simply opened up their investing app or glanced at a financial news summary for Friday, it would look like a quiet session in the stock market today. The S&P 500 was up less than 0.02%, in what appeared to be a sleepy trading session ahead of a three-day holiday weekend. However, it was
Shares of Teva Pharmaceuticals (NYSE:TEVA) were up over 9% in late trading on Feb.12. The company posted EPS and revenue that exceeded analysts’ expectations. Source: JHVEPhoto / Shutterstock.com The earnings report made it three quarters in a row that Teva stock has beaten revenue expectations. The bottom line number marked a reversal from the third
The last time I weighed in on Boeing (NYSE:BA), I noted that the stock “appears to have priced in a substantial amount of fear and negativity. Many investors also believe Boeing stock has hit bottom.” Source: Alex JW Robinson / Shutterstock.com That was on January 17, when BA stock was trading at $321.09. At the
A man runs past the New York Stock Exchange (NYSE). Bloomberg The portfolio manager who helps run a mutual fund that consistently beats the market and its peers said the key to his success is being able to wait for stocks to pop. The D.F. Dent Premier Growth Fund, which has returned over 15% annually
Friday was another mostly listless day for equities, as the major benchmarks spent much of the session searching for direction only to find little of it on a sluggish, light volume day in advance of a long weekend. Source: Provided by Finviz The S&P 500 gained 0.18%. The Dow Jones Industrial Average slipped 0.08%. The Nasdaq
On paper, there’s an intriguing bull case for miner Freeport-McMoRan (NYSE:FCX). Freeport-McMoRan stock looks cheap. Copper prices have dipped of late, but have at least one important long-term tailwind. And Freeport has steadily improved its balance sheet in recent years, cutting net debt by over $12 billion between the end of 2015 and the end
Source: Hairem / Shutterstock.com When you think of all the coolest tech advancements in the works, from virtual reality (VR) to self-driving cars to artificial intelligence, I want you to think of one thing: NVIDIA (NASDAQ:NVDA). And, specifically, NVIDIA’s signature technology: the graphic processing unit (GPU). In a nutshell, every computer needs a processor to
Wedbush Securities’ Dan Ives praised Tesla’s announcement on Thursday morning of a new $2 billion common stock offering. “It’s a smart, strategic move,” Ives said on “Squawk Box.” “It takes any doomsday scenario around cash crunch … off the table.” Shares of Tesla, which have skyrocketed recently, were under some pressure on Thursday after the
Traders work on the floor at the New York Stock Exchange. Brendan McDermid | Reuters Stocks are likely to remain hostage to developments involving the coronavirus in the week ahead, and even so, the market could continue to hit new highs. Economists have been reducing China’s growth outlook for the quarter, with some seeing little
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 19
- Next Page »